Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 10 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: Q4Q492
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_SKI1_1 | 127 | 131 | PF00082 | 0.296 |
DEG_APCC_DBOX_1 | 126 | 134 | PF00400 | 0.496 |
DOC_MAPK_MEF2A_6 | 123 | 130 | PF00069 | 0.496 |
DOC_PP4_FxxP_1 | 58 | 61 | PF00568 | 0.496 |
DOC_WW_Pin1_4 | 117 | 122 | PF00397 | 0.416 |
DOC_WW_Pin1_4 | 95 | 100 | PF00397 | 0.465 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.615 |
LIG_LIR_Apic_2 | 57 | 61 | PF02991 | 0.507 |
LIG_LIR_Gen_1 | 135 | 142 | PF02991 | 0.550 |
LIG_LIR_Gen_1 | 53 | 61 | PF02991 | 0.493 |
LIG_LIR_Gen_1 | 70 | 81 | PF02991 | 0.493 |
LIG_LIR_Nem_3 | 135 | 139 | PF02991 | 0.496 |
LIG_LIR_Nem_3 | 53 | 58 | PF02991 | 0.493 |
LIG_LIR_Nem_3 | 70 | 76 | PF02991 | 0.493 |
LIG_PDZ_Class_2 | 137 | 142 | PF00595 | 0.468 |
LIG_Pex14_1 | 136 | 140 | PF04695 | 0.549 |
LIG_SH2_GRB2like | 109 | 112 | PF00017 | 0.493 |
LIG_SH2_STAT5 | 109 | 112 | PF00017 | 0.493 |
LIG_SH2_STAT5 | 134 | 137 | PF00017 | 0.520 |
LIG_SUMO_SIM_anti_2 | 43 | 48 | PF11976 | 0.493 |
LIG_SUMO_SIM_par_1 | 43 | 48 | PF11976 | 0.456 |
LIG_TRAF2_1 | 28 | 31 | PF00917 | 0.493 |
LIG_TRAF2_1 | 67 | 70 | PF00917 | 0.493 |
LIG_WRC_WIRS_1 | 55 | 60 | PF05994 | 0.496 |
MOD_CDK_SPxK_1 | 117 | 123 | PF00069 | 0.416 |
MOD_CK1_1 | 95 | 101 | PF00069 | 0.455 |
MOD_CK2_1 | 25 | 31 | PF00069 | 0.296 |
MOD_GlcNHglycan | 21 | 24 | PF01048 | 0.498 |
MOD_GlcNHglycan | 27 | 30 | PF01048 | 0.295 |
MOD_GlcNHglycan | 94 | 97 | PF01048 | 0.271 |
MOD_GSK3_1 | 113 | 120 | PF00069 | 0.444 |
MOD_GSK3_1 | 134 | 141 | PF00069 | 0.480 |
MOD_GSK3_1 | 36 | 43 | PF00069 | 0.445 |
MOD_N-GLC_1 | 36 | 41 | PF02516 | 0.237 |
MOD_PIKK_1 | 134 | 140 | PF00454 | 0.476 |
MOD_PKA_2 | 6 | 12 | PF00069 | 0.597 |
MOD_Plk_4 | 40 | 46 | PF00069 | 0.547 |
MOD_ProDKin_1 | 117 | 123 | PF00069 | 0.416 |
MOD_ProDKin_1 | 95 | 101 | PF00069 | 0.465 |
TRG_ENDOCYTIC_2 | 55 | 58 | PF00928 | 0.594 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1ILL9 | Leptomonas seymouri | 53% | 100% |
A0A0R6XWV6 | Leishmania donovani | 92% | 99% |
A0A0S4J1P4 | Bodo saltans | 30% | 78% |
A4I8W3 | Leishmania infantum | 94% | 100% |
E9B3T2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 99% |